Immunicum is open to discuss potential collaborations and license agreements with partners in academia and the pharmaceutical/biotech industry. We are devoted to maximizing the commercial and therapeutic potential of our research in immuno-oncology. By combining our internal expertise and technologies with external research & development teams and forefront oncology innovations, we believe we can create powerful synergies.

Contact Us